ARTLVSCDT• 3 Months (Normalized)
ARTL vs CDT (Artelo Biosciences Inc. vs CDT Equity Inc.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-54.55%
Artelo Biosciences Inc.
Normalized Baseline0.00%
CDT Performance $0.14
+%
CDT Equity Inc.
Normalized Baseline0.00%
Alpha Spread Margin CDT LEADS
-54.55 pts
CDT outperforming by 54.55 percentage points
ARTLCDT
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL CDT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(60 dates)
| Date | ARTL Price | ARTL Gain (%) | CDT Price | CDT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -54.55% | $- | - | |
| Sep 24, 2026 | $5.17 | -48.25% | $- | - | |
| Sep 23, 2026 | $7.31 | -26.83% | $0.14 | -97.27% | +70.44% |
| Sep 22, 2026 | $4.15 | -58.46% | $0.14 | -97.13% | +38.67% |
| Sep 21, 2026 | $4.10 | -58.96% | $0.15 | -96.88% | +37.92% |
| Sep 18, 2026 | $3.94 | -60.56% | $0.17 | -96.48% | +35.92% |
| Sep 17, 2026 | $3.97 | -60.26% | $0.19 | -96.15% | +35.89% |
| Sep 16, 2026 | $3.75 | -62.46% | $0.20 | -95.99% | +33.53% |
| Sep 15, 2026 | $5.34 | -46.55% | $0.20 | -95.89% | +49.34% |
| Sep 14, 2026 | $4.87 | -51.25% | $0.22 | -95.57% | +44.32% |
| Sep 11, 2026 | $5.43 | -45.65% | $0.25 | -94.94% | +49.29% |
| Sep 10, 2026 | $5.63 | -43.64% | $0.35 | -93.02% | +49.38% |
| Sep 09, 2026 | $5.98 | -40.14% | $0.60 | -87.85% | +47.71% |
| Sep 08, 2026 | $6.19 | -38.04% | $0.62 | -87.51% | +49.47% |
| Sep 04, 2026 | $6.04 | -39.54% | $0.63 | -87.35% | +47.81% |
Page 1 of 4